FDA Safety Warning For Invokana, Other SGLT2 Inhibitor Type 2 Diabetes...

The new Invokana website was launched to provide the public with updated information on the potential association between the use of SGLT2 inhibitors like Invokana and diabetic ketoacidosis.(PRWeb June 11, 2015)Read the full story at http://www.prweb.com/releases/invokana-ketoacidosis/invokana-lawsuit/prweb12783059.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news